IP Library › Assignment 029255/0034
Patent Assignment
Reel/Frame 029255/0034

Assignment of Assignor's Interest

Recorded: 2012-11-07 Pages: 5
Assignors
STEADMAN, BRYAN
Executed: 2012-09-19
TAYLOR, ROSS
Executed: 2012-09-20
Assignee
LIGOCYTE PHARMACEUTICALS, INC.
2155 ANALYSIS DRIVE, BOZEMAN, MONTANA, 59718
Covered Property (1)
Targeted Heterologous Antigen Presentation on Calicivirus Virus-Like Particles
Patent: 8,980,275 →
Application: 13/574,756 →
Publication: US 2013/0052216
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Mar 26, 2013
From: LIGOCYTE PHARMACEUTICALS, INC.
To: TAKEDA VACCINES (MONTANTA), INC.
Reel/Frame 030089/0045 →
Corrective Assignment to Correct the Patents Where Name Change Was Recorded. Remove from 5578309, 6630146, 6488929, 6309642, 6403090, 6391587, 5756095 and 7481997 Previously Recorded on Reel 030089 Frame 0045. Assignor(S) Hereby Confirms the Name Change to Be Recorded in Pats 8409590, 7955603; Apps 12531248, 13330854, 12678813, 12765641, 13023363, 13574756, 61663218.. Jun 7, 2013
From: LIGOCYTE PHARMACEUTICALS, INC.
To: TAKEDA VACCINES (MONTANA), INC.
Reel/Frame 030591/0525 →
Merger Feb 6, 2014
From: TAKEDA VACCINES (MONTANA), INC.; INVIRAGEN, INC.
To: TAKEDA VACCINES, INC.
Reel/Frame 032163/0024 →